1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network" is currently closed and not accepting applications.
The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This initiative aims to address roadblocks in multi-center clinical trials and advance the science of clinical trials by developing and implementing innovative solutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network Agency: National Institutes of Health Assistance Listings: 93. 350 -- National Center for Advancing Translational Sciences Last Updated: July 20, 2026 View version history on Grants.
gov The Clinical and Translational Science Awards Program Trial Innovation Network (TIN) is a collaborative initiative aimed at addressing critical roadblocks in the design and implementation of multi-center clinical trials.
The goal of the TIN is to execute trials better, faster, and more cost-efficiently, as well as serve as a national laboratory to study, understand, and innovate the process of conducting multi-center clinical trials.
The purpose of the issuance of the Next Generation of the TIN Notice of Funding Opportunity (NOFO) is to advance the science of clinical trials by developing and implementing innovative solutions to address challenges at the clinical trial and trial network levels.
Topics of interest include, but are not limited to, safety monitoring tools and resources, trial leader training and mentorship, digital health technologies, genomic capacity, and disease progression modeling. style="margin-left:0px;"> Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
This is a Forecast that will invite applications from all eligible organizations to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered for funding.
Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) For-profit organizations other than small businesses Public and Indian housing authorities City or township governments Federally recognized Native American tribal governments Special district governments Private institutions of higher education Public and state institutions of higher education Independent school districts Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations; Grantor contact information Division of Clinical Innovation, NCATS Please contact via e-mail.
No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofit organizations (with or without 501(c)(3)), other Native American tribal organizations, small businesses, for-profit organizations other than small businesses, public and Indian housing authorities, city or tow…. Confirm the full requirements in the official notice before applying.
The current listing shows see official notice (awards made under Sections 301 and 405 of the Public Health Service Act). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 20, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network is funded by National Center for Advancing Translational Sciences (NCATS), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This program provides support for institutions to develop and implement mentored research career development programs in clinical and translational science. It aims to nurture the next generation of translational researchers within the CTSA Program network.
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This grant program supports institutional research training grants to create, provide, and disseminate clinical and translational science training and career support programs for individuals seeking a PhD or an equivalent research health professional degree.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article